Recurrent Pregnancy Loss Analysis

Recurrent Pregnancy Loss in Reproductive Medicine

Recurrent Pregnancy Loss (RPL), also referred to as recurrent miscarriage, is generally defined as the loss of two or more pregnancies before fetal viability.

Pregnancy loss can occur due to several genetic, anatomical, hormonal, metabolic, immunological, embryological, or male factor-related causes. In many cases, recurrent pregnancy loss is multifactorial, requiring systematic clinical evaluation rather than reliance on a single investigation.

At Krishna IVF, recurrent pregnancy loss analysis is approached through individualized assessment and step-wise evaluation based on reproductive history, clinical findings, laboratory investigations, imaging studies, and where appropriate, genetic assessment.

Understanding Recurrent Pregnancy Loss

Human reproduction is biologically complex, and a significant proportion of conceptions do not progress to live birth. Early pregnancy loss may occur because of chromosomal abnormalities, implantation-related factors, uterine conditions, endocrine disorders, immunological causes, male factor abnormalities, or other reproductive factors.

Not all pregnancy losses occur for the same reason, and the evaluation approach may differ depending on:

  • • gestational age at pregnancy loss
  • • number of previous losses
  • • maternal age
  • • paternal age
  • • previous live births
  • • embryo or fetal findings where available
  • • reproductive and medical history
  • • associated fertility factors

Careful interpretation of clinical history is therefore an important part of recurrent pregnancy loss analysis.

Causes That May Contribute to Recurrent Pregnancy Loss
Genetic and Chromosomal Factors

Chromosomal abnormalities are among the most common causes of early pregnancy loss, particularly during the first trimester.

Evaluation may include:

  • • parental karyotyping where indicated
  • • assessment for balanced translocations
  • • genetic analysis of products of conception where available
  • • review of reproductive history and family history

Maternal age and paternal age may both influence the likelihood of chromosomal abnormalities.

Uterine and Anatomical Factors

Structural abnormalities involving the uterus may interfere with implantation or pregnancy continuation.

Assessment may include evaluation for:

  • • uterine septum
  • • fibroids
  • • endometrial polyps
  • • adenomyosis
  • • congenital uterine abnormalities
  • • intrauterine adhesions

3D and 4D pelvic ultrasound evaluation may be used as part of uterine assessment. In selected cases, hysteroscopy or laparoscopy may be advised.

Hormonal and Metabolic Factors

Hormonal and metabolic disorders may contribute to recurrent pregnancy loss in some patients.

Assessment may include:

  • • thyroid function
  • • prolactin levels
  • • diabetes evaluation
  • • insulin resistance assessment where appropriate
  • • ovarian function assessment
  • • other endocrine investigations depending on clinical findings

Metabolic and hormonal stability are important components of reproductive health and implantation support.

Immunological and Thrombophilia-Related Factors

Certain immunological conditions and thrombophilia-related disorders may increase the risk of pregnancy loss.

Assessment may include evaluation for:

  • • antiphospholipid antibody syndrome (APS)
  • • autoimmune conditions where clinically indicated
  • • thrombophilia-related factors in selected patients

Antiphospholipid antibody syndrome is recognized as one of the important potentially treatable causes associated with recurrent pregnancy loss.

Male Factor Evaluation

Male reproductive factors may contribute to recurrent pregnancy loss and embryo developmental abnormalities.
Assessment may include:

  • • semen analysis
  • • sperm morphology and motility evaluation
  • • sperm DNA fragmentation assessment where indicated
  • • CASA analysis
  • • review of medical, metabolic, and lifestyle factors

Male obesity, diabetes, smoking, and sperm DNA damage may influence embryo development and reproductive outcomes.

Infection Screening

Selected patients may undergo infection-related evaluation depending on clinical findings and reproductive history.

This may include:

  • • blood investigations
  • • vaginal or cervical screening
  • • PCR-based testing where clinically indicated

Infection screening should be individualized rather than performed indiscriminately in all cases.

Step-Wise Workup Approach

At Krishna IVF, recurrent pregnancy loss evaluation is approached through a step-wise clinical assessment strategy.

The objective is to understand whether pregnancy loss is primarily related to:

  • • embryonic or chromosomal abnormality,
  • or
  • • maternal, uterine, hormonal, immunological, metabolic, or male factor-related causes affecting continuation of pregnancy.

The evaluation process may include:

  • • detailed reproductive and medical history
  • • physical examination
  • • pedigree chart analysis where appropriate
  • • advanced pelvic ultrasound evaluation
  • • hormonal and metabolic investigations
  • • immunological assessment
  • • semen analysis and sperm chromatin assessment
  • • genetic evaluation where indicated
  • • uterine cavity assessment
  • • infection screening in selected cases

The sequence of investigations is individualized based on clinical findings rather than applying all investigations uniformly to every patient.

Individualized Treatment Planning

Management planning depends on:

  • • identified contributing factors
  • • reproductive history
  • • age and ovarian reserve
  • • genetic findings where applicable
  • • uterine assessment
  • • associated fertility factors
  • • previous pregnancy outcomes
  • • time-related reproductive considerations

Treatment approaches may therefore vary significantly between patients.

Possible management strategies may include:

  • • correction of uterine abnormalities where indicated
  • • hormonal or metabolic optimization
  • • thrombophilia-related treatment in selected cases
  • • lifestyle modification
  • • sperm-related evaluation and treatment
  • • assisted reproductive approaches where appropriate
  • • genetic counselling in selected situations

Treatment decisions should be individualized and based on clinical assessment rather than generalized protocols alone.

Clinical Approach at Krishna IVF

At Krishna IVF, recurrent pregnancy loss analysis is approached through coordinated reproductive medicine evaluation involving clinical, embryological, genetic, hormonal, metabolic, and male factor assessment where appropriate.

The focus is on:

  • • evidence-based evaluation
  • • individualized investigation planning
  • • step-wise workup
  • • reproductive risk assessment
  • • patient counselling regarding possible contributing factors
  • • individualized treatment planning

Clear communication regarding limitations, variability in outcomes, and possible uncertainty in diagnosis forms an important part of recurrent pregnancy loss counselling.

Important Considerations

In some patients, a definite cause for recurrent pregnancy loss may not be identified despite detailed evaluation.

At the same time, identification of a contributing factor does not always guarantee that future pregnancy loss can be completely prevented.

Reproductive outcomes continue to depend on multiple biological and clinical variables, many of which interact simultaneously.

Careful reassessment, individualized planning, and evidence-based reproductive care remain important components of recurrent pregnancy loss management.

Scroll to Top